Announced Wed, 8 Oct · 12:29 IST
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Compliance View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
GlaxoSmithKline Pharmaceuticals Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory compliance filing related to the company's depository operations and share-related processes. No financial figures, dates, or material business details were disclosed in the announcement.
Likely market impact
This is a standard compliance filing with no material impact on the company's financials, operations, or stock price. Shareholders need not take any action.